ADC Therapeutics SA (ADCT)
1.44
-0.16
(-10.00%)
USD |
NYSE |
Oct 23, 16:00
1.44
0.00 (0.00%)
After-Hours: 20:00
ADC Therapeutics Gross Profit Margin (Quarterly) : 87.80% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.80% |
| March 31, 2026 | 82.12% |
| December 31, 2025 | 92.14% |
| September 30, 2025 | 91.95% |
| June 30, 2025 | 91.10% |
| March 31, 2025 | 87.57% |
| December 31, 2024 | 87.20% |
| September 30, 2024 | 91.05% |
| June 30, 2024 | 88.20% |
| March 31, 2024 | 81.43% |
| December 31, 2023 | 92.76% |
| Date | Value |
|---|---|
| September 30, 2023 | 92.46% |
| June 30, 2023 | 94.13% |
| March 31, 2023 | 96.34% |
| December 31, 2022 | 99.54% |
| September 30, 2022 | 98.60% |
| June 30, 2022 | 94.45% |
| March 31, 2022 | 97.64% |
| December 31, 2021 | 93.20% |
| September 30, 2021 | 91.18% |
| June 30, 2021 | 79.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 87.80% |
| AC Immune SA | 0.00% |
| CRISPR Therapeutics AG | -337.8% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.17% |
| Return on Invested Capital | -94.23% |
| Profit Margin (Quarterly) | -86.06% |
| Operating Margin (Quarterly) | -117.9% |
| Return on Net Operating Assets | -219.6% |